NCT01147029View on ClinicalTrials.gov

GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy

PHASE1TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

angiogenesis inhibitor GSAO

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

Trial Locations (2)

M20 4BX

Christie Hospital, Manchester

OX3 7LJ

Churchill Hospital, Oxford

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER

NCT01147029 - GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | Biotech Hunter | Biotech Hunter